Table 1 Patient characteristics
n (%) | |
|---|---|
Total n = 54 | |
Age | |
Median (range) | 51 (20–65) |
Pathology, n (%) | |
SCC | 44 (79%) |
CAC | 10 (21%) |
FIGO stage, n (%) | |
I | 18 (33%) |
II | 14 (26%) |
III | 21 (39%) |
IV | 1 (2%) |
Radiotherapy days | |
Median (range) | 36 days (31–45 days) |
GTV prescription dose | |
Median (range) | 50 Gy (40–65 Gy) |